Loading insider details...
Beta
Latest Form 4 (Aug 10, 2026): Conversion of 1,599,993 BLSM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 10, 2026 | BlossomHill Therapeutics, Inc. (BLSM) | Conversion | 1,599,993 | n/a |
| Jul 6, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Other (see footnotes) | 4,528,186 | n/a |
| Jun 18, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/Award | 31,675 | n/a |
| Apr 30, 2026 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) | Sale | 109,331 | $9.79M |
| Jan 26, 2026 | Helix Acquisition Corp. III (HLXC) | Grant/Award | 497,500 | $4.97M |
| Dec 15, 2025 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Sale | 30,029 | $344.0K |
| Dec 8, 2025 | EyePoint, Inc. (EYPT) | Sale | 60,000 | $942.2K |
| Oct 1, 2025 | MoonLake Immunotherapeutics (MLTX) | Sale | 70,748 | $663.6K |
| Aug 13, 2025 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Exercise/Conversion | 4,172,126 | n/a |
| Jun 13, 2025 | Biomea Fusion, Inc. (BMEA) | Grant/Award | 91,970 | n/a |